Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

The effect of ω-3 polyunsaturated fatty acids on the liver lipidome, proteome and bile acid profile: parenteral versus enteral administration.

Bechynska K, Daskova N, Vrzackova N, Harant K, Heczková M, Podzimkova K, Bratova M, Dankova H, Berkova Z, Kosek V, Zelenka J, Hajslova J, Sedlacek R, Suttnar J, Hlavackova A, Bartonova L, Cahova M.

Sci Rep. 2019 Dec 13;9(1):19097. doi: 10.1038/s41598-019-54225-8.

2.

Phase I/Ib study of carfilzomib and panobinostat with or without dexamethasone in patients with relapsed/refractory multiple myeloma.

Manasanch EE, Shah JJ, Lee HC, Weber DM, Thomas SK, Amini B, Olsem J, Crumpton B, Morphey A, Berkova Z, Feng L, Orlowski RZ.

Haematologica. 2019 Aug 14. pii: haematol.2019.225375. doi: 10.3324/haematol.2019.225375. [Epub ahead of print]

3.

A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysis.

Manasanch EE, Han G, Mathur R, Qing Y, Zhang Z, Lee H, Weber DM, Amini B, Berkova Z, Eterovic K, Zhang S, Zhang J, Song X, Mao X, Morgan M, Feng L, Baladandayuthapani V, Futreal A, Wang L, Neelapu SS, Orlowski RZ.

Blood Adv. 2019 Aug 13;3(15):2400-2408. doi: 10.1182/bloodadvances.2019000300. Erratum in: Blood Adv. 2019 Sep 24;3(18):2712.

4.

Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma.

Zhuang J, Shirazi F, Singh RK, Kuiatse I, Wang H, Lee HC, Berkova Z, Berger A, Hyer M, Chattopadhyay N, Syed S, Shi JQ, Yu J, Shinde V, Tirrell S, Jones RJ, Wang Z, Davis RE, Orlowski RZ.

Blood. 2019 Apr 4;133(14):1572-1584. doi: 10.1182/blood-2018-06-859686. Epub 2019 Feb 8.

PMID:
30737236
5.

Bortezomib, lenalidomide, and dexamethasone with panobinostat for front-line treatment of patients with multiple myeloma who are eligible for transplantation: a phase 1 trial.

Manasanch EE, Shah JJ, Lee HC, Weber DM, Thomas SK, Amini B, Feng L, Berkova Z, Hildebrandt M, Orlowski RZ.

Lancet Haematol. 2018 Dec;5(12):e628-e640. doi: 10.1016/S2352-3026(18)30174-1.

PMID:
30501870
6.

Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191.

Ni H, Shirazi F, Baladandayuthapani V, Lin H, Kuiatse I, Wang H, Jones RJ, Berkova Z, Hitoshi Y, Ansell SM, Treon SP, Thomas SK, Lee HC, Wang Z, Davis RE, Orlowski RZ.

Clin Cancer Res. 2018 Dec 15;24(24):6408-6420. doi: 10.1158/1078-0432.CCR-17-3265. Epub 2018 Aug 20.

7.

Protein targeting chimeric molecules specific for bromodomain and extra-terminal motif family proteins are active against pre-clinical models of multiple myeloma.

Zhang X, Lee HC, Shirazi F, Baladandayuthapani V, Lin H, Kuiatse I, Wang H, Jones RJ, Berkova Z, Singh RK, Lu J, Qian Y, Raina K, Coleman KG, Crews CM, Li B, Wang H, Hailemichael Y, Thomas SK, Wang Z, Davis RE, Orlowski RZ.

Leukemia. 2018 Oct;32(10):2224-2239. doi: 10.1038/s41375-018-0044-x. Epub 2018 Mar 27.

8.

The Optimal Timing for Pancreatic Islet Transplantation into Subcutaneous Scaffolds Assessed by Multimodal Imaging.

Gálisová A, Fábryová E, Sticová E, Kosinová L, Jirátová M, Herynek V, Berková Z, Kříž J, Hájek M, Jirák D.

Contrast Media Mol Imaging. 2017 Dec 26;2017:5418495. doi: 10.1155/2017/5418495. eCollection 2017.

9.

Truncated protein tyrosine phosphatase receptor type O suppresses AKT signaling through IQ motif containing GTPase activating protein 1 and confers sensitivity to bortezomib in multiple myeloma.

Wang H, Baladandayuthapani V, Wang Z, Lin H, Berkova Z, Davis RE, Yang L, Orlowski RZ.

Oncotarget. 2017 Dec 7;8(69):113858-113873. doi: 10.18632/oncotarget.23017. eCollection 2017 Dec 26.

10.

Nkx6.1 decline accompanies mitochondrial DNA reduction but subtle nucleoid size decrease in pancreatic islet β-cells of diabetic Goto Kakizaki rats.

Špaček T, Pavluch V, Alán L, Capková N, Engstová H, Dlasková A, Berková Z, Saudek F, Ježek P.

Sci Rep. 2017 Nov 15;7(1):15674. doi: 10.1038/s41598-017-15958-6.

11.

Targeting nucleolin for better survival in diffuse large B-cell lymphoma.

Jain N, Zhu H, Khashab T, Ye Q, George B, Mathur R, Singh RK, Berkova Z, Wise JF, Braun FK, Wang X, Patel K, Xu-Monette ZY, Courty J, Young KH, Sehgal L, Samaniego F.

Leukemia. 2018 Mar;32(3):663-674. doi: 10.1038/leu.2017.215. Epub 2017 Jul 10.

12.

Benefits of Islet Transplantation as an Alternative to Pancreas Transplantation: Retrospective Study of More Than 10 Ten Years of Experience in a Single Center.

Voglová B, Zahradnická M, Girman P, Kríž J, Berková Z, Koblas T, Vávrová E, Németová L, Kosinová L, Habart D, Fábryová E, Dovolilová E, Leontovyc I, Neškudla T, Peregrin J, Kovác J, Lipár K, Kocík M, Marada T, Svoboda J, Saudek F.

Rev Diabet Stud. 2017 Spring;14(1):10-21. doi: 10.1900/RDS.2017.14.10. Epub 2017 Jun 12.

13.

Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myeloma.

Baljevic M, Zaman S, Baladandayuthapani V, Lin YH, de Partovi CM, Berkova Z, Amini B, Thomas SK, Shah JJ, Weber DM, Fu M, Cleeland CS, Wang XS, Stellrecht CM, Davis RE, Gandhi V, Orlowski RZ.

Ann Hematol. 2017 Jun;96(6):977-985. doi: 10.1007/s00277-017-2980-3. Epub 2017 Mar 23.

14.

[Islet transplantation as a treatment for hypoglycemia unawareness syndrome. Evaluation of the pilot program and comparison with pancreas transplantation].

Zahradnická M, Girman P, Kříž J, Berková Z, Koblas T, Vávrová E, Kosinová L, Habart D, Fábryová E, Dovolilová E, Neškudla T, Peregrin J, Kováč J, Lipár K, Kočík M, Németová L, Svoboda J, Saudek F.

Cas Lek Cesk. Winter 2016;155(7):349-356. Czech.

PMID:
27990829
15.

Lipasin/betatrophin is differentially expressed in liver and white adipose tissue without association with insulin resistance in Wistar and Goto-Kakizaki rats.

Cahová M, Habart D, Olejár T, Berková Z, Papáčková Z, Daňková H, Lodererova A, Heczková M, Saudek F.

Physiol Res. 2017 May 4;66(2):273-281. Epub 2016 Dec 16.

16.

Combining Donor Characteristics with Immunohistological Data Improves the Prediction of Islet Isolation Success.

Berkova Z, Saudek F, Girman P, Zacharovova K, Kriz J, Fabryova E, Leontovyc I, Koblas T, Kosinova L, Neskudla T, Vavrova E, Habart D, Loukotova S, Zahradnicka M, Lipar K, Voska L, Skibova J.

J Diabetes Res. 2016;2016:4214328. Epub 2016 Oct 10.

17.

Automated Analysis of Microscopic Images of Isolated Pancreatic Islets.

Habart D, Švihlik J, Schier J, Cahová M, Girman P, Zacharovová K, Berková Z, Kříž J, Fábryová E, Kosinová L, Papáčková Z, Kybic J, Saudek F.

Cell Transplant. 2016 Dec 13;25(12):2145-2156. doi: 10.3727/096368916X692005. Epub 2016 Jun 9.

PMID:
27302978
18.

Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma: an open-label phase I trial.

Shah JJ, Feng L, Thomas SK, Berkova Z, Weber DM, Wang M, Qazilbash MH, Champlin RE, Mendoza TR, Cleeland C, Orlowski RZ.

Blood Cancer J. 2016 Feb 12;6:e396. doi: 10.1038/bcj.2016.4.

19.

Delta Cell Hyperplasia in Adult Goto-Kakizaki (GK/MolTac) Diabetic Rats.

Alán L, Olejár T, Cahová M, Zelenka J, Berková Z, Smětáková M, Saudek F, Matěj R, Ježek P.

J Diabetes Res. 2015;2015:385395. doi: 10.1155/2015/385395. Epub 2015 Jul 6.

20.

Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-γ.

Tanese K, Hashimoto Y, Berkova Z, Wang Y, Samaniego F, Lee JE, Ekmekcioglu S, Grimm EA.

J Invest Dermatol. 2015 Nov;135(11):2901. doi: 10.1038/jid.2015.259. Epub 2015 Jul 16. No abstract available.

21.

Targeting Wnt pathway in mantle cell lymphoma-initiating cells.

Mathur R, Sehgal L, Braun FK, Berkova Z, Romaguerra J, Wang M, Rodriguez MA, Fayad L, Neelapu SS, Samaniego F.

J Hematol Oncol. 2015 Jun 6;8:63. doi: 10.1186/s13045-015-0161-1.

22.

Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-γ.

Tanese K, Hashimoto Y, Berkova Z, Wang Y, Samaniego F, Lee JE, Ekmekcioglu S, Grimm EA.

J Invest Dermatol. 2015 Nov;135(11):2775-2784. doi: 10.1038/jid.2015.204. Epub 2015 Jun 3. Erratum in: J Invest Dermatol. 2015 Nov;135(11):2901.

23.

Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas.

Samaniego F, Hagemeister F, Romaguera JE, Fanale MA, Pro B, McLaughlin P, Rodriguez MA, Neelapu SS, Fayad L, Younes A, Feng L, Berkova Z, Khashab T, Sehgal L, Vega-Vasquez F, Kwak LW.

Br J Haematol. 2015 Jun;169(6):814-23. doi: 10.1111/bjh.13367. Epub 2015 Mar 31.

24.

Inhibition of methyltransferases accelerates degradation of cFLIP and sensitizes B-cell lymphoma cells to TRAIL-induced apoptosis.

Braun FK, Mathur R, Sehgal L, Wilkie-Grantham R, Chandra J, Berkova Z, Samaniego F.

PLoS One. 2015 Mar 4;10(3):e0117994. doi: 10.1371/journal.pone.0117994. eCollection 2015.

25.

HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer.

Zhu H, Berkova Z, Mathur R, Sehgal L, Khashab T, Tao RH, Ao X, Feng L, Sabichi AL, Blechacz B, Rashid A, Samaniego F.

Mol Cancer Res. 2015 May;13(5):809-18. doi: 10.1158/1541-7786.MCR-14-0241. Epub 2015 Feb 12.

26.

CD74 interferes with the expression of fas receptor on the surface of lymphoma cells.

Berkova Z, Wang S, Ao X, Wise JF, Braun FK, Rezaeian AH, Sehgal L, Goldenberg DM, Samaniego F.

J Exp Clin Cancer Res. 2014 Oct 10;33:80. doi: 10.1186/s13046-014-0080-y.

27.

Lymphoid hyperplasia and lymphoma in KSHV K1 transgenic mice.

Berkova Z, Wang S, Sehgal L, Patel KP, Prakash O, Samaniego F.

Histol Histopathol. 2015 May;30(5):559-68. doi: 10.14670/HH-30.559. Epub 2014 Oct 10.

28.

90Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease.

Samaniego F, Berkova Z, Romaguera JE, Fowler N, Fanale MA, Pro B, Shah JJ, McLaughlin P, Sehgal L, Selvaraj V, Braun FK, Mathur R, Feng L, Neelapu SS, Kwak LW.

Br J Haematol. 2014 Oct;167(2):207-13. doi: 10.1111/bjh.13021. Epub 2014 Jul 8.

PMID:
25040450
29.

FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.

Sehgal L, Mathur R, Braun FK, Wise JF, Berkova Z, Neelapu S, Kwak LW, Samaniego F.

Leukemia. 2014 Dec;28(12):2376-87. doi: 10.1038/leu.2014.126. Epub 2014 Apr 3.

30.

In vivo visualization of cells labeled with superparamagnetic iron oxides by a sub-millisecond gradient echo sequence.

Deligianni X, Jirák D, Berková Z, Hájek M, Scheffler K, Bieri O.

MAGMA. 2014 Aug;27(4):329-37. doi: 10.1007/s10334-013-0422-3. Epub 2013 Nov 30.

PMID:
24292067
31.

Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex.

Wise JF, Berkova Z, Mathur R, Zhu H, Braun FK, Tao RH, Sabichi AL, Ao X, Maeng H, Samaniego F.

Blood. 2013 Jun 6;121(23):4729-39. doi: 10.1182/blood-2012-12-471094. Epub 2013 Apr 18.

32.

Gadolinium- and manganite-based contrast agents with fluorescent probes for both magnetic resonance and fluorescence imaging of pancreatic islets: a comparative study.

Berkova Z, Jirak D, Zacharovova K, Lukes I, Kotkova Z, Kotek J, Kacenka M, Kaman O, Rehor I, Hajek M, Saudek F.

ChemMedChem. 2013 Apr;8(4):614-21. doi: 10.1002/cmdc.201200439. Epub 2013 Jan 11.

PMID:
23316021
33.

Processing of superparamagnetic iron contrast agent ferucarbotran in transplanted pancreatic islets.

Zacharovová K, Berková Z, Jirák D, Herynek V, Vancová M, Dovolilová E, Saudek F.

Contrast Media Mol Imaging. 2012 Nov-Dec;7(6):485-93. doi: 10.1002/cmmi.1477.

PMID:
22991314
34.

Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma.

Kuhn DJ, Berkova Z, Jones RJ, Woessner R, Bjorklund CC, Ma W, Davis RE, Lin P, Wang H, Madden TL, Wei C, Baladandayuthapani V, Wang M, Thomas SK, Shah JJ, Weber DM, Orlowski RZ.

Blood. 2012 Oct 18;120(16):3260-70. doi: 10.1182/blood-2011-10-386789. Epub 2012 Aug 29.

35.

The peptide derived from the Ig-like domain of human herpesvirus 8 K1 protein induces death in hematological cancer cells.

Daniluk U, Kerros C, Tao RH, Wise JF, Ao X, Berkova Z, Samaniego F.

J Exp Clin Cancer Res. 2012 Aug 28;31:69. doi: 10.1186/1756-9966-31-69.

36.
37.

Detection of pancreatic islet allograft impairment in advance of functional failure using magnetic resonance imaging.

Kriz J, Jirak D, Berkova Z, Herynek V, Lodererova A, Girman P, Habart D, Hajek M, Saudek F.

Transpl Int. 2012 Feb;25(2):250-60. doi: 10.1111/j.1432-2277.2011.01403.x. Epub 2011 Dec 21.

38.

Assessment of mitochondrial DNA as an indicator of islet quality: an example in Goto Kakizaki rats.

Alán L, Špaček T, Zelenka J, Tauber J, Berková Z, Zacharovová K, Saudek F, Ježek P.

Transplant Proc. 2011 Nov;43(9):3281-4. doi: 10.1016/j.transproceed.2011.09.055.

PMID:
22099777
39.

The effect of epigenetic factors on differentiation of pancreatic progenitor cells into insulin-producing cells.

Leontovyč I, Koblas T, Pektorova L, Zacharovova K, Berkova Z, Saudek F.

Transplant Proc. 2011 Nov;43(9):3212-6. doi: 10.1016/j.transproceed.2011.10.025.

PMID:
22099760
40.

Improved detection of pancreatic islets in vivo using double contrast.

Herynek V, Berková Z, Dovolilová E, Jirák D, Kříž J, Girman P, Saudek F, Hájek M.

Contrast Media Mol Imaging. 2011 Jul-Aug;6(4):308-13. doi: 10.1002/cmmi.432.

PMID:
21861290
41.

PMLRARα binds to Fas and suppresses Fas-mediated apoptosis through recruiting c-FLIP in vivo.

Tao RH, Berkova Z, Wise JF, Rezaeian AH, Daniluk U, Ao X, Hawke DH, Karp JE, Lin HK, Molldrem JJ, Samaniego F.

Blood. 2011 Sep 15;118(11):3107-18. doi: 10.1182/blood-2011-04-349670. Epub 2011 Jul 29.

42.

[Islet transplantation for treatment of type-1 diabetes mellitus].

Saudek F, Girman P, Kríz J, Berková Z, Zacharovová K, Koblas T, Pektorová L, Vávrová E, Mindlová M, Habart D, Peregrin J, Lipár K, Oliverius M, Dovolilová E, Cíhalová E, Bobek V.

Cas Lek Cesk. 2011;150(1):49-55. Czech.

PMID:
21404489
43.

Magnetic resonance imaging of pancreatic islets transplanted into the liver in humans.

Saudek F, Jirák D, Girman P, Herynek V, Dezortová M, Kríz J, Peregrin J, Berková Z, Zacharovová K, Hájek M.

Transplantation. 2010 Dec 27;90(12):1602-6.

PMID:
21197715
44.

An acidic pH and activation of phosphoinositide 3-kinase stimulate differentiation of pancreatic progenitors into insulin-producing cells.

Koblas T, Zacharovova K, Berkova Z, Girman P, Saudek F.

Transplant Proc. 2010 Jul-Aug;42(6):2075-80. doi: 10.1016/j.transproceed.2010.05.087.

PMID:
20692412
45.

Cyclodextrin-based bimodal fluorescence/MRI contrast agents: an efficient approach to cellular imaging.

Kotková Z, Kotek J, Jirák D, Jendelová P, Herynek V, Berková Z, Hermann P, Lukes I.

Chemistry. 2010 Sep 3;16(33):10094-102. doi: 10.1002/chem.200903519.

PMID:
20583046
46.

In vivo differentiation of human umbilical cord blood-derived cells into insulin-producing beta cells.

Koblas T, Zacharovová K, Berková Z, Leontovic I, Dovolilová E, Zámecník L, Saudek F.

Folia Biol (Praha). 2009;55(6):224-32.

47.

4Pi microscopy reveals an impaired three-dimensional mitochondrial network of pancreatic islet beta-cells, an experimental model of type-2 diabetes.

Dlasková A, Spacek T, Santorová J, Plecitá-Hlavatá L, Berková Z, Saudek F, Lessard M, Bewersdorf J, Jezek P.

Biochim Biophys Acta. 2010 Jun-Jul;1797(6-7):1327-41. doi: 10.1016/j.bbabio.2010.02.003. Epub 2010 Feb 6.

48.

Milatuzumab - a promising new immunotherapeutic agent.

Berkova Z, Tao RH, Samaniego F.

Expert Opin Investig Drugs. 2010 Jan;19(1):141-9. doi: 10.1517/13543780903463854. Review.

PMID:
19968579
49.

Mechanism of Fas signaling regulation by human herpesvirus 8 K1 oncoprotein.

Berkova Z, Wang S, Wise JF, Maeng H, Ji Y, Samaniego F.

J Natl Cancer Inst. 2009 Mar 18;101(6):399-411. doi: 10.1093/jnci/djn516. Epub 2009 Mar 10. Erratum in: J Natl Cancer Inst. 2013 Nov 20;105(22):1763.

50.

How to use image analysis for islet counting.

Girman P, Berkova Z, Dobolilova E, Saudek F.

Rev Diabet Stud. 2008 Spring;5(1):38-46. doi: 10.1900/RDS.2008.5.38. Epub 2008 May 10.

Supplemental Content

Loading ...
Support Center